Norton Cancer Institute ( Site 0116) — Louisville, Kentucky

Norton Cancer Institute ( Site 0116) is a clinical research site located in Louisville, Kentucky, United States 40217.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Norton Cancer Institute ( Site 0116) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Esophageal Squamous Cell Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Norton Cancer Institute ( Site 0116)?

Norton Cancer Institute ( Site 0116) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Norton Cancer Institute ( Site 0116) conducted?

Norton Cancer Institute ( Site 0116) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Esophageal Squamous Cell Carcinoma.

Is Norton Cancer Institute ( Site 0116) accredited by Crixeo Health?

Norton Cancer Institute ( Site 0116) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Norton Cancer Institute ( Site 0116)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.